Skip to content

Incidence of Influenza Infections and Determination of Vaccination Coverage Rate Among Healthcare Workers

Incidence of Influenza Infections and Determination of Vaccination Coverage Rate Among Hospital and GPs Healthcare Workers During the 2019/2020 Epidemic Season

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04223544
Enrollment
250
Registered
2020-01-10
Start date
2020-01-13
Completion date
2020-04-03
Last updated
2020-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attitude of Health Personnel, Influenza, Vaccination

Keywords

Influenza, Vaccination Coverage Rate, Healthcare Workers, General Practice, Point of Care Testing

Brief summary

The main aim of research is to determine of the prevalence of influenza virus and influenza vaccination coverage rate among hospital and GPs healthcare workers. Course of research: Participation in the study is voluntary and carried out after the consent of the examined person. The examination consists of: 1) completing the questionnaire and 2) taking the throat swab twice by the researcher. Two throat swab samples will be taken at the same time. Both samples will be used for virological examination to determine the presence of influenza virus material using non-invasive tests: one sample will be analyzed by a quick 'on-site' test - Flu SensDx kit, while the other sample will be transported to the laboratory, where the reverse transcriptase polymerase chain reaction (RT-PCR) - reference method - will be performed to confirm the presence of influenza genetic material. Swabs are planned to be collected during the 2019/2020 influenza epidemic season (January-March). In the last stage of the study, the results obtained from the survey questionnaire and the results of virological tests will be subject to statistical analysis and based on the data obtained, conclusions will be drawn from the study, indicating their practical application. The results obtained from this study will be used to develop a quality improvement program to control influenza virus infection, which will improve the safety of both patients and medical staff.

Interventions

DIAGNOSTIC_TESTInfluenza POC and laboratory testing

Participation in the study is voluntary and carried out after the consent of the examined person. The examination consists of: 1) completing the questionnaire and 2) taking the throat swab twice by the researcher. Two throat swab samples will be taken at the same time. Both samples will be used for virological examination to determine the presence of influenza virus material using non-invasive tests: one sample will be analyzed by a quick 'on-site' test - Flu SensDx kit, while the other sample will be transported to the laboratory, where the reverse transcriptase polymerase chain reaction (RT-PCR) - reference method - will be performed to confirm the presence of influenza genetic material. Swabs are planned to be collected during the 2019/2020 influenza epidemic season (January-March).

Sponsors

Wroclaw Medical University
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Healthcare worker of selected General Practices or hospitals wards

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Influenza InfectionsJanuary-March 2020Incidence of influenza will be determined of results of POC and laboratory testing
Vaccination Coverage RateJanuary-March 2020Vaccination Coverage Rate will be determined of survey questionnaires

Countries

Poland

Contacts

Primary ContactMichal Jedrzejek
michaljedrzejek@gmail.com+48691399392
Backup ContactMichal Jedrzejek
+48691399392

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026